Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2023 Earnings Call

Operator: Good afternoon, and welcome to Oncolytics Biotech's Fourth Quarter and Full Year 2023 Conference Call. All participants are now in a listen-only mode.

Related Keywords

Germany , San Diego , California , United States , Canada , German , Canadian , American , Louise Chen , John Newman , Matt Coffey , Patrick Trucchio , Soumit Roy , Jon Patton , Allison Hagerman , Carvey Leung , Pat Andrews , Luis Santos , Tom Heineman , Manufacturing Organization , Contract Development , Product Development , American Cancer Society , Pancreatic Cancer Action Network , Nasdaq , Pfizer , Jones Research , Oncolytics Biotech , Global Coalition For Adaptive Research , Oncolytics Biotech Inc , Call Transcript March , Fourth Quarter , Full Year , Investor Relations , Chief Executive Officer , Chief Financial Officer , Kirk Look , Chief Medical Officer , Vice President , Pancreatic Ductal Adenocarcinoma , Global Coalition , Adaptive Research , New Year , Wall Street Picked These , They John ,